Cargando…
Effects of ACEI/ARB or CCB use on atrial fibrillation in hypertensive patients following permanent pacemaker implantation
AIMS: Permanent pacemaker implantation (PPI) combined with hypertension leads to a higher risk of new-onset atrial fibrillation (NOAF) for patients. Hence, it is essential to study how to reduce this risk. Currently, the effects of the two common anti-hypertensive drugs, angiotensin-converting enzym...
Autores principales: | Liu, Zhijie, Bian, Ning, Wu, Shaorong, Cao, Yantao, Su, Yiting, Li, Wenying, Li, Hairui, Lan, Xianwu, Jiang, Can, Fan, Yiming, Guo, Jun, Chen, Dongdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324512/ https://www.ncbi.nlm.nih.gov/pubmed/37424921 http://dx.doi.org/10.3389/fcvm.2023.1191539 |
Ejemplares similares
-
Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension
por: Ma, Jing, et al.
Publicado: (2021) -
ACEIs and ARBs and Their Correlation with COVID-19: A Review
por: Yehualashet, Awgichew Shewasinad, et al.
Publicado: (2020) -
The role of ACEIs/ARBs in COVID-19: Friend or foe?
por: Zhou, Zhe, et al.
Publicado: (2020) -
Withdrawal of ACEIs or ARBs in hospitalised patients with COVID-19
Publicado: (2021) -
A meta-analysis evaluating indirectly GLP-1 receptor agonists and arrhythmias in patients with type 2 diabetes and myocardial infarction
por: Liu, Zhijie, et al.
Publicado: (2022)